Kura Oncology (KURA) Reports Q3 Loss, Lags Revenue Estimates

Kura Oncology (KURA) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of $0.57. This compares to a loss of $0.63 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -49.12%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $0.15 per share when it actually produced a loss of $0.75, delivering a surprise of -600%.Over the last four quarters, the ...